Barinthus Biotherapeutics plc

BRNS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$110,662$142,090$194,385$214,054
Short-Term Investments$0$0$0$0
Receivables$12,998$7,939$18,045$11,716
Inventory$0$0$0$0
Other Curr. Assets$2,082$6,876$611$995
Total Curr. Assets$125,742$156,905$213,041$226,765
Property Plant & Equip (Net)$11,757$19,402$15,710$9,086
Goodwill$0$12,209$12,209$12,630
Intangibles$21,947$25,108$28,269$31,430
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$881$882$976$804
Total NC Assets$34,585$57,601$57,164$53,950
Other Assets$0$0$0$0
Total Assets$160,327$214,506$270,205$280,715
Liabilities
Payables$2,474$1,601$3,748$2,419
Short-Term Debt$1,920$1,785$433$682
Tax Payable$2,416$0$0$0
Deferred Revenue$1,738$0$0$182
Other Curr. Liab.$7,109$9,212$8,061$7,875
Total Curr. Liab.$15,657$12,598$12,242$11,158
LT Debt$10,087$11,191$8,340$6,540
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$438$574$3,746$8,084
Other NC Liab.$4,010$3,148$2,676$2,371
Total NC Liab.$14,535$14,913$14,762$16,995
Other Liabilities$0$0$0$0
Cap. Leases$12,007$12,976$8,773$7,063
Total Liabilities$30,192$27,511$27,004$28,153
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$237,664-$176,590-$103,243-$108,585
AOCI-$25,868-$23,315-$33,460-$8,488
Other Equity$393,560$386,688$379,598$369,197
Total Equity$130,029$186,784$242,896$252,125
Supplemental Information
Minority Interest$106$211$305$437
Total Liab. & Tot. Equity$160,327$214,506$270,205$280,715
Net Debt-$98,655-$129,114-$185,612-$206,832